Lakefront Biotherapeutics NV (GXEA.F) Q1 2025 Earnings

12FebConfirmed
Q2 2024
Q3 2024
Q4 2024
Q1 2025
-0.76
-0.39
-0.01
0.36

Details

Expected EPS
-0.5090631829958541
Actual EPS
0.287721229129126
Surprise EPS
0.8
Surprise Percent
+156.52%

Description

Lakefront Biotherapeutics NV (GXEA.F) has reported earnings of 0.287721229129126 per share for Q1 2025.

0 Comments

Share your thoughts